157 related articles for article (PubMed ID: 19192119)
1. The association of depression with platelet activation: evidence for a treatment effect.
Morel-Kopp MC; McLean L; Chen Q; Tofler GH; Tennant C; Maddison V; Ward CM
J Thromb Haemost; 2009 Apr; 7(4):573-81. PubMed ID: 19192119
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of platelet activation markers in aspirin-sensitive asthmatics and normal subjects.
Taylor ML; Misso NL; Stewart GA; Thompson PJ
Clin Exp Allergy; 1996 Feb; 26(2):202-15. PubMed ID: 8835129
[TBL] [Abstract][Full Text] [Related]
3. Course of platelet activation markers after ischemic stroke.
Marquardt L; Ruf A; Mansmann U; Winter R; Schuler M; Buggle F; Mayer H; Grau AJ
Stroke; 2002 Nov; 33(11):2570-4. PubMed ID: 12411644
[TBL] [Abstract][Full Text] [Related]
4. Can flow cytometric detection of platelet activation early in pregnancy predict the occurrence of preeclampsia? A prospective study.
Konijnenberg A; van der Post JA; Mol BW; Schaap MC; Lazarov R; Bleker OP; Boer K; Sturk A
Am J Obstet Gynecol; 1997 Aug; 177(2):434-42. PubMed ID: 9290465
[TBL] [Abstract][Full Text] [Related]
5. High plasma serotonin levels in primary pulmonary hypertension. Effect of long-term epoprostenol (prostacyclin) therapy.
Kéreveur A; Callebert J; Humbert M; Hervé P; Simonneau G; Launay JM; Drouet L
Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2233-9. PubMed ID: 11031209
[TBL] [Abstract][Full Text] [Related]
6. In vivo platelet activation is increased during sleep in patients with obstructive sleep apnea syndrome.
Geiser T; Buck F; Meyer BJ; Bassetti C; Haeberli A; Gugger M
Respiration; 2002; 69(3):229-34. PubMed ID: 12097766
[TBL] [Abstract][Full Text] [Related]
7. Depression is associated with an increase in the expression of the platelet adhesion receptor glycoprotein Ib.
Walsh MT; Dinan TG; Condren RM; Ryan M; Kenny D
Life Sci; 2002 May; 70(26):3155-65. PubMed ID: 12008098
[TBL] [Abstract][Full Text] [Related]
8. P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction.
van der Zee PM; Biró E; Ko Y; de Winter RJ; Hack CE; Sturk A; Nieuwland R
Clin Chem; 2006 Apr; 52(4):657-64. PubMed ID: 16439610
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric analysis of platelet activation markers CD62P and CD63 in patients with coronary artery disease.
Murakami T; Komiyama Y; Masuda M; Kido H; Nomura S; Fukuhara S; Karakawa M; Iwasaka T; Takahashi H
Eur J Clin Invest; 1996 Nov; 26(11):996-1003. PubMed ID: 8957206
[TBL] [Abstract][Full Text] [Related]
10. Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet P-selectin as indexes of platelet function in atrial fibrillation: a comparison of "healthy control subjects" and "disease control subjects" in sinus rhythm.
Choudhury A; Chung I; Blann AD; Lip GY
J Am Coll Cardiol; 2007 May; 49(19):1957-64. PubMed ID: 17498581
[TBL] [Abstract][Full Text] [Related]
11. Platelet activation markers in patients with nephrotic syndrome. A comparative study of different platelet function tests.
Sirolli V; Ballone E; Garofalo D; Merciaro G; Settefrati N; Di Mascio R; Di Gregorio P; Bonomini M
Nephron; 2002 Jul; 91(3):424-30. PubMed ID: 12119472
[TBL] [Abstract][Full Text] [Related]
12. Extensive platelet activation in preeclampsia compared with normal pregnancy: enhanced expression of cell adhesion molecules.
Konijnenberg A; Stokkers EW; van der Post JA; Schaap MC; Boer K; Bleker OP; Sturk A
Am J Obstet Gynecol; 1997 Feb; 176(2):461-9. PubMed ID: 9065199
[TBL] [Abstract][Full Text] [Related]
13. Platelet activation in diabetic cardiovascular autonomic neuropathy.
Rauch U; Ziegler D; Piolot R; Schwippert B; Benthake H; Schultheiss HP; Tschoepe D
Diabet Med; 1999 Oct; 16(10):848-52. PubMed ID: 10547212
[TBL] [Abstract][Full Text] [Related]
14. Activation of circulating platelets in patients with peripheral arterial disease during digital subtraction angiography and percutaneous transluminal angioplasty.
Buchholz AM; Bruch L; Schulte KL
Thromb Res; 2003 Jan; 109(1):13-22. PubMed ID: 12679127
[TBL] [Abstract][Full Text] [Related]
15. Comparison of activation process of platelets and neutrophils after coronary stent implantation versus balloon angioplasty for stable angina pectoris.
Inoue T; Sohma R; Miyazaki T; Iwasaki Y; Yaguchi I; Morooka S
Am J Cardiol; 2000 Nov; 86(10):1057-62. PubMed ID: 11074199
[TBL] [Abstract][Full Text] [Related]
16. Platelet microparticles and soluble P selectin in peripheral artery disease: relationship to extent of disease and platelet activation markers.
Tan KT; Tayebjee MH; Lynd C; Blann AD; Lip GY
Ann Med; 2005; 37(1):61-6. PubMed ID: 15902848
[TBL] [Abstract][Full Text] [Related]
17. Preanalytical requirements for flow cytometric evaluation of platelet activation: choice of anticoagulant.
Mody M; Lazarus AH; Semple JW; Freedman J
Transfus Med; 1999 Jun; 9(2):147-54. PubMed ID: 10354385
[TBL] [Abstract][Full Text] [Related]
18. Increased platelet-monocyte aggregates and cardiovascular disease in end-stage renal failure patients.
Ashman N; Macey MG; Fan SL; Azam U; Yaqoob MM
Nephrol Dial Transplant; 2003 Oct; 18(10):2088-96. PubMed ID: 13679485
[TBL] [Abstract][Full Text] [Related]
19. Platelet activation markers and the primary antiphospholipid syndrome (PAPS).
Joseph JE; Harrison P; Mackie IJ; Machin SJ
Lupus; 1998; 7 Suppl 2():S48-51. PubMed ID: 9814673
[TBL] [Abstract][Full Text] [Related]
20. Reduction of platelet activity markers in type II hypercholesterolemic patients by a HMG-CoA-reductase inhibitor.
Huhle G; Abletshauser C; Mayer N; Weidinger G; Harenberg J; Heene DL
Thromb Res; 1999 Sep; 95(5):229-34. PubMed ID: 10515287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
